These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3758110)

  • 1. Is there a need for alternative approaches in the therapy of cerebrovascular disorders?
    Hartmann A
    Eur Neurol; 1986; 25 Suppl 1():7-26. PubMed ID: 3758110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nervous disease & Ca antagonist].
    Otomo E
    No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium antagonists in the therapy of cerebrovascular diseases].
    Cosmi F
    Clin Ter; 1985 Mar; 112(5):465-8. PubMed ID: 4017471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium channel blockers in therapy of neurologic diseases].
    Wessely P; Wöber-Bingöl C
    Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists: stroke therapy coming of age.
    Wong MC; Haley EC
    Stroke; 1990 Mar; 21(3):494-501. PubMed ID: 2155484
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on calcium antagonists in cerebrovascular diseases.
    Toni D; Frontoni M; Argentino C; Sacchetti ML; De Michele M; Fieschi C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S10-4. PubMed ID: 1726729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of calcium and the significance of calciumantagonists in some neurological and neurosurgical diseases.
    Gelmers HJ
    Clin Neurol Neurosurg; 1983; 85(4):213-24. PubMed ID: 6317248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channels and calcium channel antagonists.
    Greenberg DA
    Ann Neurol; 1987 Apr; 21(4):317-30. PubMed ID: 2437852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical potential for the use of neuroprotective agents. A brief overview.
    Trembly B
    Ann N Y Acad Sci; 1995 Sep; 765():1-20; discussion 26-7. PubMed ID: 7486597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Calcium antagonists and cerebral circulation].
    Bes A; Géraud G; Fabre N
    Rev Prat; 1988 Nov; 38(27):1983-5. PubMed ID: 3206150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of calcium antagonists in the treatment of vascular diseases].
    Mayerhofer S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials.
    Olesen J
    Eur Neurol; 1990; 30 Suppl 2():31-4; discussion 39-41. PubMed ID: 2180716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute stroke with calcium antagonists.
    Hülser PJ; Kornhuber AW; Kornhuber HH
    Eur Neurol; 1990; 30 Suppl 2():35-8; discussion 39-41. PubMed ID: 2180717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine in acute ischemic stroke: a pilot study.
    Limburg M; Hijdra A
    Eur Neurol; 1990; 30(3):121-2. PubMed ID: 2358004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of flunarizine on regional cerebral blood flow in common and complicated migraine. Pilot study.
    Lagrèze HL; Tsuda Y; Hartmann A; Bülau P
    Eur Neurol; 1986; 25 Suppl 1():122-6. PubMed ID: 3093236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial Doppler evaluation of cerebral hemodynamics in migraineurs during prophylactic treatment with flunarizine.
    Fiermonte G; Annulli A; Pierelli F
    Cephalalgia; 1999 Jun; 19(5):492-6. PubMed ID: 10403064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Dalal PM; Dalal KP
    J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptokinase treatment versus calcium overload blockade in experimental thromboembolic stroke.
    De Ley G; Weyne J; Demeester G; Stryckmans K; Goethals P; Leusen I
    Stroke; 1989 Mar; 20(3):357-61. PubMed ID: 2922775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.